These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 25533124)

  • 21. Importance of PPAR alpha for the effects of growth hormone on hepatic lipid and lipoprotein metabolism.
    Ljungberg A; Lindén D; Améen C; Bergström G; Oscarsson J
    Growth Horm IGF Res; 2007 Apr; 17(2):154-64. PubMed ID: 17307376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic basis and treatment of citrin deficiency.
    Hayasaka K
    J Inherit Metab Dis; 2021 Jan; 44(1):110-117. PubMed ID: 32740958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impairments of hepatic gluconeogenesis and ketogenesis in PPARα-deficient neonatal mice.
    Cotter DG; Ercal B; d'Avignon DA; Dietzen DJ; Crawford PA
    Am J Physiol Endocrinol Metab; 2014 Jul; 307(2):E176-85. PubMed ID: 24865983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel PPARα agonist MHY553 alleviates hepatic steatosis by increasing fatty acid oxidation and decreasing inflammation during aging.
    Kim SM; Lee B; An HJ; Kim DH; Park KC; Noh SG; Chung KW; Lee EK; Kim KM; Kim DH; Kim SJ; Chun P; Lee HJ; Moon HR; Chung HY
    Oncotarget; 2017 Jul; 8(28):46273-46285. PubMed ID: 28545035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current treatment for citrin deficiency during NICCD and adaptation/compensation stages: Strategy to prevent CTLN2.
    Okano Y; Ohura T; Sakamoto O; Inui A
    Mol Genet Metab; 2019 Jul; 127(3):175-183. PubMed ID: 31255436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CDKN2A/p16INK4a suppresses hepatic fatty acid oxidation through the AMPKα2-SIRT1-PPARα signaling pathway.
    Deleye Y; Cotte AK; Hannou SA; Hennuyer N; Bernard L; Derudas B; Caron S; Legry V; Vallez E; Dorchies E; Martin N; Lancel S; Annicotte JS; Bantubungi K; Pourtier A; Raverdy V; Pattou F; Lefebvre P; Abbadie C; Staels B; Haas JT; Paumelle R
    J Biol Chem; 2020 Dec; 295(50):17310-17322. PubMed ID: 33037071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of daily energy, protein, fat, and carbohydrate intake in citrin-deficient patients: Towards prevention of adult-onset type II citrullinemia.
    Okano Y; Okamoto M; Yazaki M; Inui A; Ohura T; Murayama K; Watanabe Y; Tokuhara D; Takeshima Y
    Mol Genet Metab; 2021 May; 133(1):63-70. PubMed ID: 33741270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Citrin Deficiency: Clinical and Nutritional Features.
    Komatsu M; Tanaka N; Kimura T; Yazaki M
    Nutrients; 2023 May; 15(10):. PubMed ID: 37242166
    [No Abstract]   [Full Text] [Related]  

  • 29. Aberrant miR199a-5p/caveolin1/PPARα axis in hepatic steatosis.
    Li B; Zhang Z; Zhang H; Quan K; Lu Y; Cai D; Ning G
    J Mol Endocrinol; 2014 Dec; 53(3):393-403. PubMed ID: 25312970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Farnesol decreases serum triglycerides in rats: identification of mechanisms including up-regulation of PPARalpha and down-regulation of fatty acid synthase in hepatocytes.
    Duncan RE; Archer MC
    Lipids; 2008 Jul; 43(7):619-27. PubMed ID: 18509688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tangshen formula attenuates hepatic steatosis by inhibiting hepatic lipogenesis and augmenting fatty acid oxidation in db/db mice.
    Kong Q; Zhang H; Zhao T; Zhang W; Yan M; Dong X; Li P
    Int J Mol Med; 2016 Dec; 38(6):1715-1726. PubMed ID: 27840945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Periostin promotes liver steatosis and hypertriglyceridemia through downregulation of PPARα.
    Lu Y; Liu X; Jiao Y; Xiong X; Wang E; Wang X; Zhang Z; Zhang H; Pan L; Guan Y; Cai D; Ning G; Li X
    J Clin Invest; 2014 Aug; 124(8):3501-13. PubMed ID: 25003192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular mechanisms of alcoholic fatty liver: role of peroxisome proliferator-activated receptor alpha.
    Crabb DW; Galli A; Fischer M; You M
    Alcohol; 2004 Aug; 34(1):35-8. PubMed ID: 15670663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential induction of genes in liver and brown adipose tissue regulated by peroxisome proliferator-activated receptor-alpha during fasting and cold exposure in acyl-CoA dehydrogenase-deficient mice.
    Goetzman ES; Tian L; Wood PA
    Mol Genet Metab; 2005 Jan; 84(1):39-47. PubMed ID: 15639194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Lack of Hepatocyte Steatosis in Adult-onset Type II Citrullinemia Patients as Assessed by 7-year Interval Paired Biopsies.
    Suzuki H; Kawamura Y; Kinowaki K; Akuta N; Kasuya K; Fujiyama S; Sezaki H; Hosaka T; Saitoh S; Kobayashi M; Kobayashi M; Arase Y; Ikeda K; Suzuki F; Suzuki Y; Kumada H
    Intern Med; 2019 Jul; 58(13):1891-1895. PubMed ID: 30799367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective effect of bicyclol on tetracycline-induced fatty liver in mice.
    Yu HY; Wang BL; Zhao J; Yao XM; Gu Y; Li Y
    Toxicology; 2009 Jul; 261(3):112-8. PubMed ID: 19427351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic derangements in deficiency of citrin, a liver-type mitochondrial aspartate-glutamate carrier.
    Saheki T; Kobayashi K; Iijima M; Moriyama M; Yazaki M; Takei Y; Ikeda S
    Hepatol Res; 2005 Oct; 33(2):181-4. PubMed ID: 16199199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatosteatosis in peroxisome deficient liver despite increased β-oxidation capacity and impaired lipogenesis.
    Peeters A; Swinnen JV; Van Veldhoven PP; Baes M
    Biochimie; 2011 Oct; 93(10):1828-38. PubMed ID: 21756965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NIK links inflammation to hepatic steatosis by suppressing PPARα in alcoholic liver disease.
    Li Y; Chen M; Zhou Y; Tang C; Zhang W; Zhong Y; Chen Y; Zhou H; Sheng L
    Theranostics; 2020; 10(8):3579-3593. PubMed ID: 32206109
    [No Abstract]   [Full Text] [Related]  

  • 40. Hepatitis C virus core protein modulates fatty acid metabolism and thereby causes lipid accumulation in the liver.
    Yamaguchi A; Tazuma S; Nishioka T; Ohishi W; Hyogo H; Nomura S; Chayama K
    Dig Dis Sci; 2005 Jul; 50(7):1361-71. PubMed ID: 16047488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.